![]() ![]() | NOEL, L., Fransolet, M., Jacobs, N., Foidart, J.-M., Nisolle, M., & Munaut, C. (2020). A paracrine interaction between granulosa cells and leukocytes in the preovulatory follicle causes the increase in follicular G-CSF levels. Journal of Assisted Reproduction and Genetics, 37, 405-416. doi:10.1007/s10815-020-01692-y ![]() |
![]() ![]() | Terren, C., Fransolet, M., Ancion, M., Nisolle, M., & Munaut, C. (23 December 2019). Slow Freezing Versus Vitrification of Mouse Ovaries: from Ex Vivo Analyses to Successful Pregnancies after Auto-Transplantation. Scientific Reports, 9 (1), 19668. doi:10.1038/s41598-019-56182-8 ![]() |
Terren, C., Fransolet, M., NISOLLE, M., & Munaut, C. (2019). Is slow-freezing still better than vitrification for ovarian tissue cryopreservation? [Poster presentation]. Séminaire des chercheurs Télévie 2019. |
Terren, C., Fransolet, M., NISOLLE, M., & Munaut, C. (2019). Comparison between two ovarian tissue cryopreservation techniques (slow-freezing versus vitrification) [Poster presentation]. BACR-Annual Meeting. |
![]() ![]() | Fransolet, M., NOEL, L., HENRY, L., LABIED, S., Blacher, S., NISOLLE, M., & Munaut, C. (2019). Evaluation of Z-VAD-FMK as an anti-apoptotic drug to prevent granulosa cell apoptosis and follicular death after human ovarian tissue transplantation. Journal of Assisted Reproduction and Genetics. doi:10.1007/s10815-018-1353-8 ![]() |
Terren, C., Fransolet, M., NISOLLE, M., & Munaut, C. (2018). Slow-freezing versus vitrification of mouse ovary: from ex vivo analyses to pregnancy after autotransplantation [Poster presentation]. Joint Meeting GIGA-Cancer Day 2018. |
![]() ![]() | Fransolet, M. (2016). Contribution to the study of restoring female fertility using a xenograft model of cropreserved ovarian tissue [Doctoral thesis, Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/315250 |
Munaut, C., Fransolet, M., LABIED, S., & NISOLLE, M. (03 June 2016). Development and assessment of a new closed system for ovarian tissue vitrification [Paper presentation]. 12ième journées scientifiques du GRECOT, Paris, France. |
Fransolet, M. (02 June 2016). Préservation de la fertilité féminine : Etude de l’effet de l’anti-apoptotique Z-VAD-FMK sur l’apoptose des cellules de la granulosa et la perte folliculaire après transplantation de tissu ovarien cryopréservé [Paper presentation]. 12ième journées scientifiques du Groupe de Recherche et d’Etude sur la Cryoconservation de l’Ovaire et du Testicule. |
![]() ![]() | Foster, B., Balassa, T., Benen, T., Dominovic, M., Elmajian, G., Florova, V., Fransolet, M., Kestlerova, A., Kmiecik, G., Kostadinova, I., Kyvelidou, C., Meggyes, M., Mincheva, M., Moro, L., Pastuschek, J., Spoldi, V., Wandernoth, P., Weber, M., Toth, B., & Markert, U. (2016). Extracellular vesicles in blood, milk and body fluids of the female and male urogenital tract and with special regard to reproduction. Critical Reviews in Clinical Laboratory Sciences. doi:10.1080/10408363.2016.1190682 ![]() |
![]() ![]() | Fransolet, M., NOEL, L., HENRY, L., LABIED, S., Noël, A., Nisolle, M., & Munaut, C. (25 January 2016). − Evaluation of Z-VAD-FMK as an anti-apoptotic drug to prevent granulosa cells apoptosis and follicle death after ovarian tissue transplantation [Poster presentation]. GIGA day. |
![]() ![]() | HENRY, L., Fransolet, M., LABIED, S., Blacher, S., MASEREEL, M.-C., Foidart, J.-M., Noël, A., Nisolle, M., & Munaut, C. (2016). Supplementation of transport and freezing media with anti-apoptotic drugs improves ovarian cortex survival. Journal of Ovarian Research. doi:10.1186/s13048-016-0216-0 ![]() |
Fransolet, M., HENRY, L., LABIED, S., Noël, A., Foidart, J.-M., NISOLLE, M., & Munaut, C. (14 June 2015). In vitro evaluation of an anti-apoptotic drug, Z-VAD-FMK, for further use in ovarian tissue transplantation [Poster presentation]. The 31th Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE), Lisbonne, Portugal. |
Fransolet, M., HENRY, L., LABIED, S., Noël, A., Foidart, J.-M., Nisolle, M., & Munaut, C. (13 May 2015). In vitro evaluation of Z-VAD-FMK, an anti-apoptotic drug, for further use in ovarian tissue transplantation [Poster presentation]. GIGA-Cancer day. |
![]() ![]() | Fransolet, M., HENRY, L., LABIED, S., Noël, A., Foidart, J.-M., Nisolle, M., & Munaut, C. (11 February 2015). In vitro evaluation of Z-VAD-FMK, an anti-apoptotic drug, for further use in ovarian tissue transplantation [Poster presentation]. Séminaire des jeunes chercheurs Télévie. |
Fransolet, M., HENRY, L., LABIED, S., Noël, A., Foidart, J.-M., Nisolle, M., & Munaut, C. (31 January 2015). Follicular maintenance after oavrian tissue transplantation with the anti-apoptotic drug Z-VAD-FMK [Poster presentation]. Meeting annuel de la Belgian Association for Cancer Research (BACR). |
![]() ![]() | HENRY, L., Fransolet, M., LABIED, S., Masereel, M.-C., Blacher, S., Donneau, A.-F., Kirschvink, N., Noël, A., Foidart, J.-M., Nisolle, M., & Munaut, C. (27 January 2015). Limitation of damage to ovarian cortex during cryopreservation by addition of anti-apoptotic drugs in transport and freezing media [Poster presentation]. GIGA day. |
Fransolet, M., HENRY, L., LABIED, S., Noël, A., Foidart, J.-M., Nisolle, M., & Munaut, C. (27 January 2015). In vitro evaluation of Z-VAD-FMK, an anti-apoptotic drug, for further use in ovarian tissue transplantation [Poster presentation]. GIGA day. |
Fransolet, M., HENRY, L., LABIED, S., Noël, A., Foidart, J.-M., Nisolle, M., & Munaut. (16 January 2015). In vitro evaluation of Z-VAD-FMK, an anti-apoptotic drug, for further use in ovarian tissue transplantation [Poster presentation]. International Society of Fertility Preservation (ISFP) meeting: “Freezing of oocytes, embryos and ovarian tissue: focus on fertility management and fertility preservation”. |
![]() ![]() | Henry, L., LABIED, S., Fransolet, M., Kirschvink, N., Blacher, S., Noël, A., Foidart, J.-M., Nisolle, M., & Munaut, C. (2015). Isoform 165 of vascular endothelial growth factor in collagen matrix improves ovine cryopreserved ovarian tissue revascularisation after xenotransplantation in mice. Reproductive Biology and Endocrinology, 13 (1), 15. doi:10.1186/s12958-015-0015-2 ![]() |
![]() ![]() | Fransolet, M., HENRY, L., LABIED, S., Noël, A., Nisolle, M., & Munaut, C. (2015). In vitro evaluation of the anti-apoptotic drug Z-VAD-FMK on human ovarian granulosa cell lines for further use in ovarian tissue transplantation. Journal of Assisted Reproduction and Genetics. doi:10.1007/s10815-015-0536-9 ![]() |
![]() ![]() | Fransolet, M., Henry, L., LABIED, S., Masereel, M.-C., Blacher, S., Noël, A., Foidart, J.-M., Nisolle, M., & Munaut, C. (2015). Influence of mouse strain on ovarian tissue recovery after engraftment with angiogenic factor. Journal of Ovarian Research, 8 (1), 14. doi:10.1186/s13048-015-0142-6 ![]() |
Fransolet, M. (19 December 2014). Female fertility preservation: Evaluation of pro‐angiogenic and anti‐apoptotic drugs for further use in ovarian tissue transplantation [Paper presentation]. GIGA‐Cancer seminar. |
![]() ![]() | HENRY, L., Fransolet, M., LABIED, S., MASEREEL, M.-C., Blacher, S., Donneau, A.-F., Kirschvink, N., Noël, A., Foidart, J.-M., Nisolle, M., & Munaut, C. (14 November 2014). Use of anti-apoptotic drugs in transport and freezing media of cryopreserved sheep ovarian cortex to improve tissue survival [Poster presentation]. 32ème meeting scientifique de la Belgian Society of Reproductive Medicine (BSRM). |
Fransolet, M., HENRY, L., LABIED, S., Noël, A., Foidart, J.-M., Nisolle, M., & Munaut, C. (14 November 2014). Potential effect of the anti-apoptotic drug Z-VAD-FMK on follicular maintenance in ovarian tissue cryopreservation [Poster presentation]. 32ème meeting scientifique de la Belgian Society of Reproductive Medicine (BSRM). |
Fransolet, M., HENRY, L., LABIED, S., Noël, A., Foidart, J.-M., Nisolle, M., & Munaut, C. (30 September 2014). Does Z-VAD-FMK treatment could decrease follicular loss after autografting of cryopreserved ovarian tissue? [Poster presentation]. Mini-symposium annuel de l’EDT-Cancérologie Expérimentale. |
Fransolet, M., HENRY, L., Blacher, S., Colige, A., Kirschvink, N., Foidart, J.-M., Noël, A., LABIED, S., Nisolle, M., & Munaut, C. (19 May 2014). Ovarian tissue recovery in SCID and NOD-SCID mice after VEGF111 or VEGF165 graft treatment [Poster presentation]. GIGA-Cancer day. |
![]() ![]() | Fransolet, M., HENRY, L., Blacher, S., Colige, A., Kirschvink, N., Foidart, J.-M., Noël, A., LABIED, S., Nisolle, M., & Munaut, C. (15 May 2014). Impact of mice strains in ovarian tissue recovery after VEGF111 or VEGF165 graft treatment [Poster presentation]. BioLiège Bioforum 2014. |
![]() ![]() | Fransolet, M., HENRY, L., Blacher, S., Colige, A., Kirschvink, N., Foidart, J.-M., Noël, A., LABIED, S., Nisolle, M., & Munaut, C. (01 February 2014). Impact of mice strains in ovarian tissue recovery after VEGF111 or VEGF165 graft treatment [Poster presentation]. Belgian Association for Cancer Research (BACR) annual meeting 2014. |
Fransolet, M., HENRY, L., Blacher, S., Colige, A., Kirschvink, N., Foidart, J.-M., Noël, A., LABIED, S., Nisolle, M., & Munaut, C. (27 January 2014). Impact of mice strains in ovarian tissue recovery after VEGF111 or VEGF165 graft treatment [Poster presentation]. GIGA day. |
![]() ![]() | Fransolet, M., Labied, S., Henry, L., Masereel, M.-C., Rozet, E., Kirschvink, N., Nisolle, M., & Munaut, C. (2014). Strategies for Using the Sheep Ovarian Cortex as a Model in Reproductive Medicine. PLoS ONE, 9 (3), 91073. doi:10.1371/journal.pone.0091073 ![]() |
![]() ![]() | Fransolet, M., HENRY, L., Foidart, J.-M., Noël, A., LABIED, S., Nisolle, M., & Munaut, C. (05 December 2013). Z-VAD-FMK treatment prevents granulosa cells apoptosis induced by etoposide but not by hypoxia and serum starvation in vitro [Poster presentation]. Séminaire des chercheurs Télévie 2014. |
Fransolet, M., HENRY, L., Foidart, J.-M., Noël, A., LABIED, S., Nisolle, M., & Munaut, C. (07 November 2013). Z-VAD-FMK treatment prevents granulosa cells apoptosis induced by etoposide but not by hypoxia and serum starvation in vitro [Poster presentation]. 3rd World Congress of the International Society for Fertility Preservation (ISFP). |
Fransolet, M. (18 September 2013). Do anti-apoptotic drugs could improve tissue viability after ovarian cortical fragments transplantation? [Paper presentation]. 10ème congrès de l’European Society of Gynecology. |
HENRY, L., Fransolet, M., LABIED, S., Munaut, C., Kirschvink, N., Noël, A., Nisolle, M., & Foidart, J.-M. (17 May 2013). Effect of anti-apoptotic drugs to prevent follicles loss during ovarian cortex transport and cryopreservation [Poster presentation]. GIGA-Cancer day. |
Fransolet, M., HENRY, L., Foidart, J.-M., Noël, A., LABIED, S., Nisolle, M., & Munaut, C. (17 May 2013). Do anti-apoptotic drugs prevent follicle loss after ovarian cortical graft to patient in remission? [Poster presentation]. GIGA-Cancer day. |
![]() ![]() | HENRY, L., Fransolet, M., LABIED, S., Munaut, C., Kirschvink, N., Noël, A., Nisolle, M., & Foidart, J.-M. (21 March 2013). Do anti-apoptotic drugs prevent follicles loss during ovarian cortex transport and cryopreservation? [Poster presentation]. The International Congress on Oncological Perspectives of Fertility Preservation: Gynecological & Breast Cancer. |
Fransolet, M., HENRY, L., Rozet, E., Blacher, S., Masereel, M.-C., Kirschvink, N., Foidart, J.-M., Noël, A., Nisolle, M., LABIED, S., & Munaut, C. (02 February 2013). How to use sheep ovarian tissue as a model to restore fertility in young women who received gonadotoxic treatment? [Poster presentation]. Belgian Association for Cancer Research (BACR) annual meeting. |
![]() ![]() | Labied, S., Delforge, Y., Munaut, C., Blacher, S., Colige, A., Delcombel, R., HENRY, L., Fransolet, M., JOUAN, C., Perrier d'Hauterive, S., Noël, A., Nisolle, M.* , & Foidart, J.-M.*. (2013). Isoform 111 of vascular endothelial growth factor (VEGF111) improves angiogenesis of ovarian tissue xenotransplantation. Transplantation, 95 (3), 426-433. doi:10.1097/TP.0b013e318279965c ![]() * These authors have contributed equally to this work. |
HENRY, L., Delforge, Y., Blacher, S., Colige, A., Delcombel, R., Fransolet, M., JOUAN, C., PERRIER d'HAUTERIVE, S., Noël, A., Nisolle, M., Foidart, J.-M., Munaut, C., & LABIED, S. (10 December 2012). Isoform 111 of vascular endothelial growth factor (VEGF111) improves angiogenesis of ovarian tissue xenotransplantation [Poster presentation]. Televie's Researchers Seminar. |
![]() ![]() | Fransolet, M., HENRY, L., Rozet, E., Blacher, S., Masereel, M.-C., Kirschvink, N., Noël, A., Foidart, J.-M., NISOLLE, M., Labied, S., & Munaut, C. (10 December 2012). Use of Sheep Ovarian Tissue as a Model to Restore Fertility in Young Cancerous Women [Poster presentation]. Séminaire des chercheurs Télévie 2013. |
![]() ![]() | HENRY, L., Fransolet, M., LABIED, S., Blacher, S., Munaut, C., Colige, A., Kirschvink, N., Noël, A., Nisolle, M., & Foidart, J.-M. (30 November 2012). Does vascular endothelial growth factor improve ovarian tissue recovery after cryopreservation? [Poster presentation]. Belgian Society of Reproductive Medicine. |
Fransolet, M., HENRY, L., Rozet, E., Blacher, S., Masereel, M.-C., Kirschvink, N., Foidart, J.-M., Noël, A., Nisolle, M., Munaut, C., & LABIED, S. (30 November 2012). Assessment of follicular density in sheep ovarian tissue and impact on experimental results [Poster presentation]. Belgian Society of Reproductive Medicine. |
Fransolet, M., HENRY, L., Blacher, S., Colige, A., Kirschvink, N., PERRIER d'HAUTERIVE, S., Foidart, J.-M., Noël, A., LABIED, S., Nisolle, M., & Munaut, C. (22 June 2012). Influence of VEGF111 treatment on ovarian tissue xenografts in different mice strains [Poster presentation]. GIGA-Cancer day. |
Fransolet, M., HENRY, L., Blacher, S., Colige, A., Kirschvink, N., PERRIER d'HAUTERIVE, S., Foidart, J.-M., Noël, A., Nisolle, M., Munaut, C., & LABIED, S. (04 May 2012). Comparison of different mice strains to test ovarian VEGF111 treated graft recovery [Poster presentation]. GIGA day. |
Fransolet, M., HENRY, L., Blacher, S., Colige, A., Kirschvink, N., PERRIER d'HAUTERIVE, S., Foidart, J.-M., Noël, A., Munaut, C., LABIED, S., & Nisolle, M. (18 April 2012). Impact of mice strains in ovarian tissue recovery after VEGF111 graft treatment [Poster presentation]. Biomedica, The European Life Sciences Summit. |
Henry, L., Fransolet, M., Labied, S., Blacher, S., Munaut, C., Colige, A., Kirschvink, N., Noël, A., Nisolle, M., & Foidart, J.-M. (2012). Does vascular endothelial growth factor improve ovarian tissue recovery after cryopreservation? In Giornale italiano di obstetricia e gynecologia (pp. 34(1):203). ![]() |
![]() ![]() | HENRY, L., Fransolet, M., LABIED, S., Blacher, S., Munaut, C., Kirschvinck, N., Noël, A., NISOLLE, M., & Foidart, J.-M. (2011). Does isoforms 111 and 165 of vascular endothelial growth factor (VEGF111 and 165) improve transplanted ovarian tissue survival? Journal of Assisted Reproduction and Genetics, 28, 1009-1010. |
![]() ![]() | LABIED, S., Delforge, Y., Blacher, S., Munaut, C., Signole, N., Colige, A., Janssen, L., HENRY, L., Fransolet, M., PERRIER d'HAUTERIVE, S., JOUAN, C., Kirschvink, N., Noël, A., NISOLLE, M., & Foidart, J.-M. (2011). Isoform 111 of vascular endothelial growth factor (VEGF111) improves angiogenesis of ovarian tissue xenotransplantation. Journal of Assisted Reproduction and Genetics, 28, 1099. |
![]() ![]() | Henry, L., Fransolet, M., LABIED, S., Blacher, S., Munaut, C., Colige, A., Kirschvink, N., Noël, A., NISOLLE, M., & Foidart, J.-M. (2011). Does isoforms 111 and 165 of vascular endothelial growth factor (VEGF111 and 165) improve transplanted ovarian tissue survival? Journal of Assisted Reproduction and Genetics, 28, 1009-10. ![]() |